Literature DB >> 9147453

[Normalization of cognitive and functional assessment instruments for dementia (NORMACODEM) (I): objectives, content and population].

J Peña-Casanova1, M Aguilar, I Bertran-Serra, P Santacruz, G Hernández, R Insa, A Pujol, J M Sol, R Blesa.   

Abstract

UNLABELLED: To adequately evaluate patients with 4 neuropsychological deficits a project for norming cognitive and functional instruments that assess dementia (NORMACODEM) was designed. Four hundred fifty-one subjects in three groups: 254 controls, 86 patients with minor memory/cognitive deficits without dementia (DWD) and 111 patients with probable Alzheimer-type dementia (ATD) according to the NINCDS/ADRDA criteria. Mini-Mental State Examination (MMSE), Alzheimer's Disease Assessment Scale (ADAS), Abbreviated Barcelona Test (ABT), Global Dementia Staging (GDS), Functional Assessment Staging (FAST), Clinical Dementia Rating (CDR), Rapid Disability Rating Scale-2 (RDRS-2), Blessed Dementia Rating Scale (BDRS), Interview for Deterioration in Daily life in Dementia (IDDD), Geriatric Evaluation by Relatives Rating Instrument (GERRI), Geriatric Depression Scale (GDS), Zung Self-Rating Anxiety Scale (ZSRAS). Descriptive statistics and analysis of variance. The characteristics of the sample were as follows. CONTROLS: 99 men, 155 women. Mean (SD) age: 64.6 (10.9) years. Mean (SD) educational level: 9.1 (4.9) years. DWD: 42 men, 44 women. Mean (SD) age: 65.8 (8.7) years. Men (SD) educational level: 8.4 (4.4) years. ATD: 48 mean, 63 women. Mean (SD) age: 68.3 (8.0) years. Mean (SD) educational level: 6.2 (4.3) years. The ATD patients were significantly older than the controls. Mean educational level was significantly lower in the ATD group than in the other two.

Entities:  

Mesh:

Year:  1997        PMID: 9147453

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  10 in total

1.  Normative data of a brief neuropsychological battery for Spanish individuals older than 49.

Authors:  Montserrat Alegret; Ana Espinosa; Georgina Vinyes-Junqué; Sergi Valero; Isabel Hernández; Lluís Tárraga; James T Becker; Mercè Boada
Journal:  J Clin Exp Neuropsychol       Date:  2011-12-13       Impact factor: 2.475

2.  Isotretinoin was not associated with depression or anxiety: A twelve-week study.

Authors:  Bella Suarez; Ana Serrano; Yves Cova; Trino Baptista
Journal:  World J Psychiatry       Date:  2016-03-22

3.  Social networks, social integration, and social engagement determine cognitive decline in community-dwelling Spanish older adults.

Authors:  María-Victoria Zunzunegui; Beatriz E Alvarado; Teodoro Del Ser; Angel Otero
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2003-03       Impact factor: 4.077

4.  Impact of COVID-19 Mandatory Social Isolation on the Development of Anxiety in Peruvian Dentistry Students: A Logistic Regression Analysis.

Authors:  César Félix Cayo-Rojas; Manuel Jesús Castro-Mena; Regina de la Caridad Agramonte-Rosell; Ana Sixtina Aliaga-Mariñas; Marysela Irene Ladera-Castañeda; Luis Adolfo Cervantes-Ganoza; Luis Claudio Cervantes-Liñán
Journal:  J Int Soc Prev Community Dent       Date:  2021-04-15

5.  From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery.

Authors:  Montserrat Alegret; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Isabel Hernández; Marta Marquié; Maitée Rosende-Roca; Ana Mauleón; Carla Abdelnour; Liliana Vargas; Ester Esteban de Antonio; Rogelio López-Cuevas; Juan Pablo Tartari; Emilio Alarcón-Martín; Lluís Tárraga; Agustín Ruiz; Mercè Boada; Sergi Valero
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Successful Working Memory Processes and Cerebellum in an Elderly Sample: A Neuropsychological and fMRI Study.

Authors:  Elkin O Luis; Gonzalo Arrondo; Marta Vidorreta; Martin Martínez; Francis Loayza; María A Fernández-Seara; María A Pastor
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

7.  Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old.

Authors:  Montserrat Alegret; Ana Espinosa; Sergi Valero; Georgina Vinyes-Junqué; Agustín Ruiz; Isabel Hernández; Maitee Rosende-Roca; Ana Mauleón; James T Becker; Lluís Tárraga; Mercè Boada
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

8.  Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM).

Authors:  Aina Soler; Guillem Amer; Alicia Leiva; Joana Ripoll; María Angeles Llorente; Alfonso Leiva; Joana Maria Taltavull; Rosa Molina; Joan Llobera
Journal:  BMC Geriatr       Date:  2019-04-11       Impact factor: 3.921

9.  Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial.

Authors:  Marta Bisbe; Andrea Fuente-Vidal; Elisabet López; Marta Moreno; Marian Naya; Claudio de Benetti; Raimon Milà; Olga Bruna; Mercè Boada; Montserrat Alegret
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

10.  A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease.

Authors:  Montserrat Alegret; Nathalia Muñoz; Natalia Roberto; Dorene M Rentz; Sergi Valero; Silvia Gil; Marta Marquié; Isabel Hernández; Catalina Riveros; Angela Sanabria; Alba Perez-Cordon; Ana Espinosa; Gemma Ortega; Ana Mauleón; Carla Abdelnour; Maitee Rosende-Roca; Kathryn V Papp; Adela Orellana; Alba Benaque; Lluís Tarraga; Agustín Ruiz; Mercè Boada
Journal:  Alzheimers Res Ther       Date:  2020-03-16       Impact factor: 6.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.